MODIFIED OLIGONUCLEOTIDES INTRIPLE HELIX FORMATION

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: N/A
Agency Tracking Number: 19145
Amount: $50,000.00
Phase: Phase I
Program: SBIR
Awards Year: 1992
Solicitation Year: N/A
Solicitation Topic Code: N/A
Solicitation Number: N/A
Small Business Information
9391 Grogans Mill Rd, The Woodlands, TX, 77380
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 Ganapathi R Revankar
 (713) 363-8761
Business Contact
Phone: () -
Research Institution
N/A
Abstract
THE PRIMARY GOAL OF THIS STUDY IS TO CHEMICALLY REFINE A CLASS OF SEQUENCE-SPECIFIC, DNA BINDING, TRIPLE HELIX-FORMING OLIGONUCLEOTIDES (TFOS). THE UNIQUE FEATURE OF THESE TFOS IS THAT BINDING OF THE THIRD STRAND TO ITS DUPLEX DNA TARGET IS PH INDEPENDENT AND IS STABILIZED BY GGC AND TAT TRIPLETS SUCH THAT THE PREFERRED ORIENTATION PLACES THE BOUND TFO ANTIPARALLEL WITH RESPECT TO MORE PURINE RICH STRAND OF THE UNDERLYING DUPLEX. OUR INITIAL STUDIES WITH A 38 BASE LONG OLIGONUCLEOTIDE (BIG38P), DESIGNED TO BIND TO THE PROMOTER REGION IN THE LONG-TERMINAL REPEAT SEQUENCE OF HUMAN IMMUNODEFICIENCY VIRUS (HIV), INDICATED THAT HIV38P HAS A TENDENCY TO SELF-ASSOCIATE DUE TO HIGH G CONTENT. SUBSEQUENT STUDIES WITH HIV38P HAVE SHOWN THAT SUBSTITUTION OF G WITH 2'-DEOXY-7-DEAZAGUANOSINE RESIDUES REDUCES THE SELF-ASSOCIATION CONSIDERABLY. THUS, SUBSTITUTION OF SOME OR ALL GUANINE RESIDUES IN HIV38P WITH SELECTED GUANINE ANALOGS MAY REDUCE OR ELIMINATE SELF-ASSOCIATION AND IMPROVE TRIPLEX FORMATION. WE WILL PREPARE TFOS CONTAINING VARIOUS LEVELS OF SUBSTITUTIONS RANGING FROM 10 TO 50% WITH 2'-DEOXY-7-DEAZAGUANOSINE OR 2'-DEOXY-6-THIOGUANOSINE EMPLOYING SOLID-PHASE PHOSPHORAMIDITE CHEMISTRY. THE MODIFIED OLIGONUCLEOTIDES THUS OBTAINED WILL BE PURIFIED AND ADEQUATELY CHARACTERIZED. THE ABILITY OF THESE NOVEL TFOS TO FORM STABLE TRIPLEXES WILL BE EVALUATED USING BAND SHIFT ANALYSIS, DNASE FOOTPRINTING EXPERIMENTS, MELTING CURVES AND CD MEASUREMENTS. IT IS HOPED THAT SUCH A SUBSTITUTION IMPROVES TIRPLE HELIX STRUCTURE, REDUCES SELF-ASSOCIATION, INCREASES BINDING AFFINITY AND ANTIVIRAL (HIV AND HSV) ACTIVITY. DETAILED BIOLOGICAL EFFECTS OF SUCH MODIFIED TFOS WILL BE ASSESSED IN PHASE II STUDIES.

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government